Yen Y - Search Results

1

Arginine Signaling and Cancer Metabolism.

Chen CL, Hsu SC, Ann DK, Yen Y, Kung HJ. Chen CL, et al. Among authors: yen y. Cancers (Basel). 2021 Jul 15;13(14):3541. doi: 10.3390/cancers13143541. Cancers (Basel). 2021. PMID: 34298755 Free PMC article. Review.

2

High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation.

Boo LM, Lin HH, Chung V, Zhou B, Louie SG, O'Reilly MA, Yen Y, Ann DK. Boo LM, et al. Among authors: yen y. Cancer Res. 2005 Aug 1;65(15):6622-30. doi: 10.1158/0008-5472.CAN-05-0086. Cancer Res. 2005. PMID: 16061642

3

SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone.

Chung V, Zhou B, Liu X, Zhu L, Boo LM, Nguyen HV, Ann DK, Song J, Chen Y, Yen Y. Chung V, et al. Among authors: yen y. Mol Cancer Ther. 2006 Mar;5(3):533-40. doi: 10.1158/1535-7163.MCT-05-0290. Mol Cancer Ther. 2006. PMID: 16546967

4

Transcriptional regulation by targeted expression of architectural transcription factor high mobility group A2 in salivary glands of transgenic mice.

Lin HH, Xiong Y, Ho YS, Zhou B, Nguyen HV, Deng H, Lee R, Yen Y, Borok Z, Ann DK. Lin HH, et al. Among authors: yen y. Eur J Oral Sci. 2007 Feb;115(1):30-9. doi: 10.1111/j.1600-0722.2007.00421.x. Eur J Oral Sci. 2007. PMID: 17305714

5

Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression.

Li X, Lee YK, Jeng JC, Yen Y, Schultz DC, Shih HM, Ann DK. Li X, et al. Among authors: yen y. J Biol Chem. 2007 Dec 14;282(50):36177-89. doi: 10.1074/jbc.M706912200. Epub 2007 Oct 17. J Biol Chem. 2007. PMID: 17942393 Free article.

6

Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.

Hu S, Yen Y, Ann D, Wong DT. Hu S, et al. Among authors: yen y. Drug Discov Today. 2007 Nov;12(21-22):911-6. doi: 10.1016/j.drudis.2007.08.008. Epub 2007 Oct 17. Drug Discov Today. 2007. PMID: 17993408 Review.

7

Suppression of nonhomologous end joining repair by overexpression of HMGA2.

Li AY, Boo LM, Wang SY, Lin HH, Wang CC, Yen Y, Chen BP, Chen DJ, Ann DK. Li AY, et al. Among authors: yen y. Cancer Res. 2009 Jul 15;69(14):5699-706. doi: 10.1158/0008-5472.CAN-08-4833. Epub 2009 Jun 23. Cancer Res. 2009. PMID: 19549901 Free PMC article.

8

p53R2 inhibits the proliferation of human cancer cells in association with cell-cycle arrest.

Zhang K, Wu J, Wu X, Wang X, Wang Y, Zhou N, Kuo ML, Liu X, Zhou B, Chang L, Ann D, Yen Y. Zhang K, et al. Among authors: yen y. Mol Cancer Ther. 2011 Feb;10(2):269-78. doi: 10.1158/1535-7163.MCT-10-0728. Epub 2011 Jan 7. Mol Cancer Ther. 2011. PMID: 21216934 Free PMC article.

9

Canonical nuclear factor κB pathway links tumorigenesis of synchronous mantle-cell lymphoma, clear-cell renal-cell carcinoma, and GI stromal tumor.

Guo R, Chang L, Liu Z, Li AX, Huang Q, Ann DK, Wang HC, Lin CW, Wu X, Yuan YC, Yen Y. Guo R, et al. Among authors: yen y. J Clin Oncol. 2011 Apr 1;29(10):e257-61. doi: 10.1200/JCO.2010.32.1802. Epub 2011 Jan 10. J Clin Oncol. 2011. PMID: 21220613 No abstract available.

10

Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.

Wang X, Liu X, Li AY, Chen L, Lai L, Lin HH, Hu S, Yao L, Peng J, Loera S, Xue L, Zhou B, Zhou L, Zheng S, Chu P, Zhang S, Ann DK, Yen Y. Wang X, et al. Among authors: yen y. Clin Cancer Res. 2011 Apr 15;17(8):2570-80. doi: 10.1158/1078-0432.CCR-10-2542. Epub 2011 Jan 20. Clin Cancer Res. 2011. PMID: 21252160 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,613 results

Search Page